GLAXF GSK plc

NEUTRAL Impact: 2/10 6-K
Horizon immediate Filed Apr 29, 2026 Processed 1mo ago SEC 0001654954-26-004056
Notable filing: 6-K
Latest settled — T+20d ⚠ clustered
GLAXF ▼ -5.58% at T+20d
NEUTRAL call ✗ call lost -5.58% · α vs SPY -11.04% · entry $27.08 → $25.57
Next anchor: T+60d in 6w
Currently $26.63 · -1.66% from $27.08 entry
Entry anchored
Apr 29, 2026
via day open
T+1d
-3.88%
call -3.88% · α -4.90%
$26.03
settled 6w ago
T+5d
-7.64%
call -7.64% · α -10.75%
$25.01
settled 5w ago
T+20d
-5.58%
call -5.58% · α -11.04%
$25.57
settled 16d ago
T+60d
call — · α —
in 6w

Price Chart

Loading chart...

Executive Summary

GSK filed a Form 6-K reporting routine share transactions by two insiders: Independent Non-Executive Director Wendy Becker purchased 4,000 ordinary shares at £19.6291 each on April 29, 2026, and Chief People Officer Diana Conrad acquired 12.874 American Depositary Shares at $54.5854 each under the GSK pension plan on April 27, 2026. These are standard insider transactions with no material financial impact or strategic significance.

Actionable Insight

These routine insider transactions are not material. Monitor GSK's upcoming quarterly earnings and pipeline updates for meaningful catalysts. No trading action warranted based on this filing.

Key Facts

  • Wendy Becker, Independent Non-Executive Director, purchased 4,000 ordinary shares at £19.6291 per share on April 29, 2026.
  • Diana Conrad, Chief People Officer, acquired 12.874 American Depositary Shares at $54.5854 per share under the GSK pension plan on April 27, 2026.
  • Both transactions were executed on public exchanges (London Stock Exchange and New York Stock Exchange).
  • No other material information was disclosed in the filing.

Financial Impact

Insider purchases total approximately £78,516 (Becker) and $703 (Conrad) — negligible relative to GSK's market cap.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
41% bullish (32 analysts)

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-004056
Document: 0001654954-26-004056-index-headers.html0001654954-26-004056
Document: 0001654954-26-004056-index.html0001654954-26-004056
Document: 0001654954-26-004056.txt0001654954-26-004056
51 reports for GLAXF
Performance horizon
42% Hit rate 5 of 12 directional calls best @ T+5▲ +7.60%Apr 1, 2026
Filters
Rows
Reports for GLAXF — sortable, filterable
Type Now
Jun 10, 2026
2d ago
6-K
NEUTRAL ★ 1/10
$23.54 awaiting T+5awaiting T+5$26.63 (+13.13%)
Jun 9, 2026
3d ago
6-K
NEUTRAL ★ 1/10
$24.66 awaiting T+5awaiting T+5$26.63 (+7.99%)
Jun 9, 2026
4d ago
6-K
BULLISH ★ 7/10
$24.66 awaiting T+5awaiting T+5$26.63 (+7.99%)
Jun 1, 2026
11d ago
6-K
NEUTRAL ★ 1/10
$24.25 $24.66▲ +1.69%▲ +4.44%$26.63 (+9.81%)
Jun 1, 2026
11d ago
6-K
NEUTRAL ★ 2/10
$24.25 $24.66▲ +1.69%▲ +4.44%$26.63 (+9.81%)
May 28, 2026
16d ago
6-K
BULLISH ★ 7/10
$24.58 $24.66▲ +0.33%▲ +0.01%$26.63 (+8.34%)
May 27, 2026
16d ago
6-K
NEUTRAL ★ 1/10
$25.57 $23.94▼ −6.37%▼ −7.58%$26.63 (+4.15%)
May 26, 2026
17d ago
6-K
NEUTRAL ★ 1/10
$25.50 $24.25▼ −4.90%▼ −5.99%$26.63 (+4.43%)
May 26, 2026
17d ago
6-K
NEUTRAL ★ 2/10
$25.50 $24.25▼ −4.90%▼ −5.99%$26.63 (+4.43%)
May 22, 2026
22d ago
6-K
NEUTRAL ★ 2/10
$26.00 $24.25▼ −6.73%▼ −8.39%$26.63 (+2.42%)
Showing 10 of 51

US Market Status

Market Closed — Opens Mon (49h 36m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access